Discover the detailed record of transactions filed by Yarema Kristin, Directeur Commercial. Insider active across 2 companies, notably Atara Biotherapeutics, Inc.. In total, 5 disclosures have been logged. Total volume traded: €66k. The latest transaction was filed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
5 of 5 declarations
Kristin Yarema is the Chief Commercial Officer at Atara Biotherapeutics, Inc. She is responsible for the commercial strategy and direction of the company's activities. Her role is crucial in developing initiatives aimed at increasing market share and strengthening the company's position in the biopharmaceutical sector. She brings her expertise in management and commercial strategy.